Dynacor Group, a Montreal-based industrial gold ore processor, has announced the appointment of Denis Rivard as its new Chief Operating Officer. This newly created role aims to support the company's expansion efforts in gold ore procession operations across different jurisdictions.

A Seasoned Professional with Extensive Experience

Denis Rivard brings with him over four decades of experience in various industries. Previously serving as the Vice President at CDPQ Infra, a renowned contractor for significant public infrastructure projects, Rivard successfully led a light-rail project from construction to commissioning.

Throughout his career, Rivard has made valuable contributions to diverse projects, including aluminum smelters, mining initiatives, export terminals, chemical and gas facilities, as well as major infrastructure developments.

A Strategic Appointment for Dynacor Group

Dynacor Group recognizes the rapid growth it is currently experiencing. Consequently, the appointment of Rivard as the Chief Operating Officer is seen as a strategic move for the corporation. With his extensive experience and exceptional leadership in project management, Rivard is expected to play a pivotal role in the company's continued success.

Kromek Group Secures $1 Million Worth of Orders in CBRN Detection Sector

Alibaba Upgrades AI Model Amid US Restrictions

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

Silk Road Medical Inc. Plunge After Medicare Decision
News

Silk Road Medical Inc. Plunge After Medicare Decision

Silk Road Medical Inc. experiences sharp decline in stock value after government ruling on Medicare coverage for carotid...

Canadian Investors Increase Holdings of Foreign Securities in June
News

Canadian Investors Increase Holdings of Foreign Securities in June

Canadian investors increased their holdings of foreign securities in June, while foreigners continued to invest in Canad...

Trump's Decision to Skip the Fox News Debate
News

Trump's Decision to Skip the Fox News Debate

Former President Donald Trump discusses his decision to skip the Fox News debate and engages in an interview with Tucker...

Lipella Pharmaceuticals Shares Skyrocket 52.2% After FDA Approval
News

Lipella Pharmaceuticals Shares Skyrocket 52.2% After FDA Approval

Lipella Pharmaceuticals' stock surges 52.2% following FDA approval of its investigational drug for oral lichen planus. C...